(19)
(11)
EP 0 929 568 A2
(12)
(43)
Date of publication:
21.07.1999
Bulletin 1999/29
(21)
Application number:
97939105.0
(22)
Date of filing:
10.09.1997
(51)
International Patent Classification (IPC):
C12N
15/
02
( . )
A61K
38/
06
( . )
A61K
39/
395
( . )
A61P
25/
00
( . )
A61P
33/
06
( . )
A61P
37/
06
( . )
C07K
5/
08
( . )
C07K
7/
06
( . )
C07K
14/
155
( . )
C07K
14/
54
( . )
C07K
16/
18
( . )
C07K
16/
44
( . )
A61K
39/
00
( . )
A61K
38/
00
( . )
A61K
38/
20
( . )
A61P
17/
00
( . )
A61P
31/
04
( . )
A61P
37/
04
( . )
A61P
43/
00
( . )
C07K
5/
10
( . )
C07K
7/
08
( . )
C07K
14/
16
( . )
C07K
16/
10
( . )
C07K
16/
24
( . )
C12P
21/
08
( . )
(86)
International application number:
PCT/IB1997/001086
(87)
International publication number:
WO 1998/010787
(
19.03.1998
Gazette 1998/11)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
11.09.1996
US 19960025180P
(71)
Applicant:
Prendergast, Patrick Thomas
Straffan Kildare (IE)
(72)
Inventor:
Prendergast, Patrick Thomas
Straffan Kildare (IE)
(74)
Representative:
Pidgeon, Robert John
Appleyard Lees 15 Clare Road
Halifax West Yorkshire HX1 2HY
Halifax West Yorkshire HX1 2HY (GB)
(54)
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF IMMUNE DISORDERS